Editorial comment on: Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature

Eur Urol. 2008 Oct;54(4):775-6. doi: 10.1016/j.eururo.2008.06.017. Epub 2008 Jun 13.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Humans
  • Male
  • Neurotoxins / therapeutic use*
  • Prostatic Hyperplasia / complications*
  • Prostatism / drug therapy*
  • Prostatism / etiology*

Substances

  • Neurotoxins
  • Botulinum Toxins, Type A